Atlas Trials

A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China

Clinical trial NCT07198620 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07198620
Sponsor
Guangdong Association of Clinical Trials
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer (NSCLC)
Start date
2025-10-01
Primary completion
2026-06-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.